TEVA Forecast — Price Target — Prediction for 2024
Teva's (TEVA) Crash Is Just Getting Started, Here Comes a 55% Bear Raid - TheStreet
Barclays Adjusts Teva Pharmaceutical Industries Price Target to $14 From $13, Maintains Overweight Rating -February 09, 2023 at 07:35 am EST | MarketScreener
UBS raises Teva price target - Globes
Will Teva Stock Break Down From Key Support?
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg